Rauwolfia and guanethidine: Pharmacology and clinical use in treatment of hypertension
dc.contributor.author | Conway, James | en_US |
dc.date.accessioned | 2006-04-13T14:55:05Z | |
dc.date.available | 2006-04-13T14:55:05Z | |
dc.date.issued | 1962-06 | en_US |
dc.identifier.citation | Conway, James (1962/06)."Rauwolfia and guanethidine: Pharmacology and clinical use in treatment of hypertension." The American Journal of Cardiology 9(6): 837-840. <http://hdl.handle.net/2027.42/32307> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T10-4BWM29W-WX/2/1ac6bfcf004d913a0ac855ea2c7224f5 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/32307 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=13881024&dopt=citation | en_US |
dc.description.abstract | Both reserpine and guanethidine appear to utilize the same fundamental pharmacological mode of action which leads to depletion of tissue catecholamines.Guanethidine produces effects on the blood pressure similar to those of the ganglion-blocking agents without the troublesome side effects. It is an extremely potent agent, however, and is likely to produce symptoms attributable to postural hypotension. | en_US |
dc.format.extent | 390807 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Rauwolfia and guanethidine: Pharmacology and clinical use in treatment of hypertension | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | From the Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA | en_US |
dc.identifier.pmid | 13881024 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/32307/1/0000375.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0002-9149(62)90206-0 | en_US |
dc.identifier.source | The American Journal of Cardiology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.